Supernus Pharmaceuticals | SUPN - 流动负债

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.56B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	流动负债	更改		日
Abbott	USD 18.38B		1.88B	2026-03
ANI Pharmaceuticals	USD 239.51M		38.6M	2026-03
Aurora Cannabis	CAD 145.94M		21.82M	2025-12
Bristol-Myers Squibb	USD 19.16B		4.26B	2026-03
Canopy Growth	CAD 98.29M		17.19M	2025-12
Cara Therapeutics	USD 11.04M		2K	2025-12
Corcept Therapeutics	USD 149.18M		16.9M	2026-03
Eisai	JPY 340.25B		47.42B	2026-03
Eli Lilly	USD 36.63B		1.41B	2026-03
Novo Nordisk	DKK 225.16B		9.5B	2026-03
Pacira	USD 108.79M		11.8M	2026-03
Perrigo	USD 997.6M		15.3M	2026-03
Pfizer	USD 34.35B		2.64B	2026-03
Supernus Pharmaceuticals	USD 373.93M		35.76M	2026-03
United Therapeutics	USD 599.1M		38.5M	2026-03
Xeris Pharmaceuticals	USD 118.59M		9.02M	2026-03